We are live on ! Find out more
SIC

Starr International Company Portfolio holdings

AUM $19.9M
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+33.25%
1 Year Est. Return
-39.69%
3 Year Est. Return
-26.08%
5 Year Est. Return
-43.79%
10 Year Est. Return
-39.24%
AUM
$49.8M
AUM Growth
+$10.2M
Cap. Flow
+$147K
Cap. Flow %
0.29%
Top 10 Hldgs %
100%
Holding
5
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
BCSF icon
Bain Capital Specialty
BCSF
+$147K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 69.43%
2 Financials 30.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNA icon
1
Moderna
MRNA
$22.1B
$25.8M 51.74%
67,000
BCSF icon
2
Bain Capital Specialty
BCSF
$815M
$11.8M 23.66%
794,543
+9,653
+1% +$147K
AZN icon
3
AstraZeneca
AZN
$263B
$5.59M 11.21%
46,500
AIG icon
4
American International
AIG
$42B
$3.45M 6.91%
62,788
JNJ icon
5
Johnson & Johnson
JNJ
$641B
$3.23M 6.48%
20,000

Similar funds

Starr International Company's Q3 2021 Portfolio in Review

As of Q3 2021, Starr International Company held 5 positions worth $49.8M, up 26% from $39.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Starr International Company opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 62% a quarter earlier, followed by Financials.

  • Starr International Company added most to Bain Capital Specialty in Q3 2021, an estimated $147K increase.
  • Starr International Company's ten largest holdings make up 100% of its $49.8M portfolio in Q3 2021.
  • Starr International Company opened 0 new positions and closed 0 in Q3 2021.
  • Starr International Company's portfolio value rose 26% quarter-over-quarter to $49.8M.

Based on Starr International Company's 13F filing for Q3 2021, filed 2 Nov 2021.